1. Home
  2. TMDX vs ACLX Comparison

TMDX vs ACLX Comparison

Compare TMDX & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Arcellx Inc.

ACLX

Arcellx Inc.

HOLD

Current Price

$68.70

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
ACLX
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.2B
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
TMDX
ACLX
Price
$136.66
$68.70
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
$133.00
$115.50
AVG Volume (30 Days)
835.5K
1.2M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
170.70
N/A
EPS
2.54
N/A
Revenue
$566,354,000.00
$35,898,000.00
Revenue This Year
$38.84
N/A
Revenue Next Year
$20.43
$302.49
P/E Ratio
$53.83
N/A
Revenue Growth
41.20
N/A
52 Week Low
$55.00
$47.86
52 Week High
$156.00
$94.07

Technical Indicators

Market Signals
Indicator
TMDX
ACLX
Relative Strength Index (RSI) 54.31 33.01
Support Level $133.50 $66.00
Resistance Level $156.00 $75.03
Average True Range (ATR) 8.50 5.23
MACD 0.41 -1.69
Stochastic Oscillator 55.98 12.96

Price Performance

Historical Comparison
TMDX
ACLX

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: